This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Abveris Inc.
Abveris Inc., a leading biotechnology company headquartered in the United States, specialises in the development of innovative antibody discovery solutions. Founded in 2012, Abveris has established itself as a key player in the biopharmaceutical industry, particularly in the areas of therapeutic antibody development and protein engineering. With a focus on utilising advanced technologies, Abveris offers unique services that streamline the antibody discovery process, ensuring high specificity and affinity. The company has achieved significant milestones, including collaborations with major pharmaceutical firms, which underscore its strong market position. Abveris continues to drive advancements in antibody therapeutics, making it a trusted partner for organisations seeking cutting-edge solutions in drug development.
DitchCarbon Score
How does Abveris Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Abveris Inc.'s score of 18 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Abveris Inc.'s reported carbon emissions
Abveris Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Twist Bioscience Corporation, which may influence its climate commitments and reporting practices. Despite the lack of direct emissions data, Abveris Inc. is part of a broader corporate family that may have established climate initiatives. However, there are no documented reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges at this time. As a subsidiary, Abveris may align its sustainability efforts with those of Twist Bioscience Corporation, which could include initiatives aimed at reducing carbon footprints and enhancing environmental responsibility. However, specific details regarding these initiatives or any inherited targets from Twist Bioscience are not available. In summary, while Abveris Inc. does not currently provide emissions data or specific climate commitments, its affiliation with Twist Bioscience Corporation may play a role in shaping its future sustainability strategies.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Abveris Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
